title: Low-dose laulimalide represents a novel molecular probe for investigating microtubule organization.
abstract: Laulimalide is a natural product that has strong taxoid-like properties but binds to a distinct site on β-tubulin in the microtubule (MT) lattice. At elevated concentrations, it generates MTs that are resistant to depolymerization, and it induces a conformational state indistinguishable from taxoid-treated MTs. In this study, we describe the effect of low-dose laulimalide on various stages of the cell cycle and compare these effects to docetaxel as a representative of taxoid stabilizers. No evidence of MT bundling in interphase was observed with laulimalide, in spite of the fact that MTs are stabilized at low dose. Cells treated with laulimalide enter mitosis but arrest at prometaphase by generating multiple asters that coalesce into supernumerary poles and interfere with the integrity of the metaphase plate. Cells with a preformed bipolar spindle exist under heightened tension under laulimalide treatment, and chromosomes rapidly shear from the plate, even though the bipolar spindle is well-preserved. Docetaxel generates a similar phenotype for HeLa cells entering mitosis, but when treated at metaphase, cells undergo chromosomal fragmentation and demonstrate reduced centromere dynamics, as expected for a taxoid. Our results suggest that laulimalide represents a new class of molecular probe for investigating MT-mediated events, such as kinetochore-MT interactions, which may reflect the location of the ligand binding site within the interprotofilament groove.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Melissa J
authors.initials: MJ
authors.lastname: Bennett
authors.forename: Gordon K
authors.initials: GK
authors.lastname: Chan
authors.forename: J B
authors.initials: JB
authors.lastname: Rattner
authors.forename: David C
authors.initials: DC
authors.lastname: Schriemer
mesh_terms: D059447:Cell Cycle Checkpoints; D019457:Chromosome Breakage; D002877:Chromosomes, Human / Q000187:drug effects / Q000378:metabolism; D000077143:Docetaxel; D004305:Dose-Response Relationship, Drug; D005455:Fluorescent Antibody Technique / Q000379:methods; D006367:HeLa Cells; D006801:Humans; D007399:Interphase; D018942:Macrolides / Q000494:pharmacology*; D008677:Metaphase; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism*; D008938:Mitosis / Q000187:drug effects; D015335:Molecular Probes / Q000378:metabolism* / Q000494:pharmacology; D008941:Spindle Apparatus / Q000187:drug effects / Q000378:metabolism; D043823:Taxoids / Q000494:pharmacology; D059008:Time-Lapse Imaging
chemical_list: D018942:Macrolides; D015335:Molecular Probes; D043823:Taxoids; C117305:laulimalide; D000077143:Docetaxel